Clinical Trial

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

Study acronym: EVANESCE-II
Recruiting
View on ClinicalTrials.gov →
Summary
A study to evaluate the safety and effectiveness of FemPulse System
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-24; most recent amendment 2026-07-10.
Status change: Not Yet Recruiting → Recruiting 2026-02-04
Trial Details
NCT Number NCT07195656
Lead Sponsor FemPulse Corporation
Collaborators: Moxie Clinical
Conditions Overactive Bladder (OAB)
Enrollment 151 participants
Start Date 2025-09-30
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-13